The integrated plasma biomarker predicted F&V intake more accurately than did plasma total cholesterol-adjusted carotenoid concentration , with the difference being significant at visit 2 ( P < 0.001 ) and with a tendency to be significant at visit 1 ( P = 0.07 ) .